rs11431031
Your query was ambiguous. Multiple possible variants found:
- chr2-86456416-ATTTTTTTTTT-A
- chr2-86456416-ATTTTTTTTTT-AT
- chr2-86456416-ATTTTTTTTTT-ATTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTT
- chr2-86456416-ATTTTTTTTTT-ATTTTTTTTTTTTTTTTTTTTT
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_018433.6(KDM3A):c.557-13_557-4delTTTTTTTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000189 in 1,057,866 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0000081 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0000011 ( 0 hom. )
Consequence
KDM3A
NM_018433.6 splice_region, intron
NM_018433.6 splice_region, intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.12
Genes affected
KDM3A (HGNC:20815): (lysine demethylase 3A) Enables androgen receptor binding activity; histone H3-methyl-lysine-9 demethylase activity; and iron ion binding activity. Involved in several processes, including androgen receptor signaling pathway; formaldehyde biosynthetic process; and histone H3-K9 demethylation. Located in nucleoplasm. Implicated in cervical cancer and colon cancer. Biomarker of Ewing sarcoma; hepatocellular carcinoma; nasopharynx carcinoma; and prostate cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000805 AC: 1AN: 124204Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
1
AN:
124204
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000107 AC: 1AN: 933662Hom.: 0 AF XY: 0.00000216 AC XY: 1AN XY: 462168
GnomAD4 exome
AF:
AC:
1
AN:
933662
Hom.:
AF XY:
AC XY:
1
AN XY:
462168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000805 AC: 1AN: 124204Hom.: 0 Cov.: 0 AF XY: 0.0000172 AC XY: 1AN XY: 58220
GnomAD4 genome
AF:
AC:
1
AN:
124204
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
58220
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at